Reuben Guttman, director at Grant & Eisenhofer, , will join China Leaders Forum 2013 (http://chinaleadersforum.com), "Will the Chinese Dream Become Long-term Investors' Dream or Nightmare?", conference that in its fifth edition is gearing up to provide the information practitioners are looking for in an open and unbiased environment, highly conducive to the most efficient and effective networking.
Mr. Guttman's practice involves complex litigation and class actions. He has represented clients in claims brought under the Federal False Claims Act, securities laws, the Price Anderson Act, Department of Energy (DOE) statutes and regulations, the Worker Adjustment and Retraining Notification Act (WARN), Racketeer Influenced and Corrupt Organizations Act (RICO) and various employment discrimination, labor and environmental statutes. He has also tried and/or litigated claims involving fraud, breach of fiduciary duty, antitrust, business interference and other common law torts.
The International Business Times has called Mr. Guttman "one of the world's most prominent whistleblower attorneys." He has served as counsel in some of the largest recoveries under the False Claims Act. In 2013, Mr. Guttman was lead counsel in an intervened case by the United States Department of Justice against Pfizer, Inc. involving the kidney-transplant drug Rapamune. On July 30, 2013, The U.S. Department of Justice announced that Pfizer had agreed to pay $491 million to settle criminal and civil charges stemming from the illegal marketing of Rapamune by Wyeth Pharmaceuticals, which was acquired by Pfizer in 2009. Mr. Guttman represented two whistleblowers---sales representative Marlene Sandler and pharmacist Scott Paris---who brought the initial action in the case, United States ex rel. Sandler et al. v. Wyeth Pharmaceuticals, Inc. Also in 2013, Mr. Guttman was lead counsel in U.S. ex rel. Kurnik v. Amgen, Inc. et al., resulting in the recovery of $24.9 million from Amgen. That case exposed kickbacks designed to increase sales of the drug Aranesp.
In 2012, he served as lead counsel for the lead whistleblower, Meredith McCoyd, in U.S. ex rel. McCoyd v. Abbott Labs, which resulted in a $1.6 billion recovery for the government. In 2012, he also represented one of the four main whistleblowers in a case against GlaxoSmithKline that returned over $3 billion to the government. Also in 2012, Mr. Guttman represented whistleblower Lynn Szymoniak whose qui tam case, involving fraudulent mortgage assignments, was resolved as part of the government's $25 billion settlement with some of the world's largest banks. He represented one of the six main whistleblowers in litigation resulting in the government's September 2009, $2.3 billion settlement with Pfizer Pharmaceutical and he served as counsel in U.S. ex rel. Johnson v. Shell Oil Co., 33 F. Supp. 2d 528 (E.D. Tex. 1999), where over $300 million was recovered from the oil industry. On behalf of a European whistleblower, Mr. Guttman was counsel in litigation that resulted in a $13 million settlement.
China Leaders Forum 2013 will provide attendees with the responses to the above-mentioned questions and the most up-to-date review of where the Asian giant stands and the challenges and opportunities for businessmen looking to expand their business with China when others only see growth contraction. Recognized experts, regulators, and strategists, will return to China Leaders Forum 2013 to provide the information practitioners are looking for in an open and unbiased environment, highly conducive to the most efficient and effective networking:
· Ann Lee, Author, What the U.S. Can Learn from China
· Crocker Coulson, President, CCG Investor Relations
· Dan David, Co-founder and Vice President, GeoInvesting
· Edgar Perez, Author, The Speed Traders, Knightmare on Wall Street
· Harry Edelson , Managing Director, Edelson Technology Partners
· James O'Neill, Managing Partner, Jin Niu Investment Management Ltd.
· Janet Stites, Publisher, China Business Knowledge
· John Allen, Chairman & CEO, Greater China Corporation
· Jonathan Krane, CEO, Harvest Krane
· Lisa Prager, Partner, Schulte Roth & Zabel
· Minggao Shen, Managing Director, Citigroup
· Ned Cloonan, Managing Director, Liberty Square Group
· Neng Wang, Chong Khoon Lin Professor of Real Estate, Columbia Business School
· Peter Halasz, Partner, Schulte Roth & Zabel
· Reuben Guttman, Director, Grant & Eisenhofer
· Robert Vambery, Professor of International Business, Lubin School of Business
China Leaders Forum 2013 is produced by Golden Networking (http://www.goldennetworking.net), the premier networking community for business executives, entrepreneurs and investors. Panelists, speakers and sponsors are invited to contact Golden Networking by sending an email to firstname.lastname@example.org.